Letters to the Editor |

Effects of NMDA Receptor Antagonists: Implications for the Pathophysiology of Schizophrenia

John H. Krystal, MD; Amit Anand, MD; Bita Moghaddam, PhD
Arch Gen Psychiatry. 2002;59(7):663-664. doi:.
Text Size: A A A
Published online


We appreciate the interest of Drs Shim and Adityanjee in the mechanistic implications of our study, which described the interactive effects of lamotrigine and ketamine in healthy human subjects.1 They question whether reductions in N-methyl-D-aspartate receptor (NMDAR) function produced by ketamine in fact enhance regional glutamatergic neurotransmission via non-NMDARs. Because of this concern, they question whether lamotrigine reduces the hyperglutamatergic effects of ketamine or whether it attenuates ketamine's effects through other mechanisms. In response to these queries, it is important to point out that the study in question is quite limited in its capacity to determine how lamotrigine attenuates ketamine's effects. The fact that lamotrigine reduced the psychotogenic and cognitive effects of ketamine, but potentiated the euphoric effects of ketamine, may have mechanistic significance. For example, it suggests that lamotrigine is not simply antagonizing the effects of ketamine at the NMDAR. Preclinical research may provide insight into the interactive effects of lamotrigine and ketamine.


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 49

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.